Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1542, Issue 1-3, 2002, Pages 209-220

  Annabi, Borhane ^a   Lachambre, Marie Paule ^a   Bousquet Gagnon, Nathalie ^a   Pageé, Martine ^a   Gingras, Denis ^a   Beéliveau, Richard ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Angiogenesis; Cancer; Glioblastoma; Green tea; Membrane type 1 matrix metalloproteinase

Indexed keywords

BREFELDIN A; CONCANAVALIN A; CYTOCHALASIN D; EPIGALLOCATECHIN GALLATE; GELATINASE A; GREEN TEA EXTRACT; MANUMYCIN; MATRIX METALLOPROTEINASE 14; POLYPHENOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMELLIA SINENSIS; CATECHIN; CELL MOVEMENT; COS CELLS; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; ENZYME PRECURSORS; FLAVONOIDS; GELATIN; GELATINASES; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PHENOLS; POLYMERS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037196553     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(01)00187-2     Document Type: Article

References (52)

1. A review of latest research findings on the health promotion properties of tea
2. Tea flavonoids and cardiovascular health
3. Inhibition of carcinogenesis by dietary polyphenolic compounds
4. Radical scavenging by flavonoid antioxidants
5. Tea and cancer
6. The chemistry of tea flavonoids
7. Green tea in chemoprevention of cancer
8. Effects of catechins on the mouse lung carcinoma cell adhesion to the endothelial cells
9. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure-activity relationship and mechanisms involved
10. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172)
11. Membrane-type metalloproteinases in tumor invasion
12. Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis
13. Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
14. Activation mechanisms of matrix metalloproteinases
15. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
16. A matrix metalloproteinase expressed on the surface of invasive tumour cells
17. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines
18. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP)
19. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
20. Elevated cyclic AMP suppresses ConA-induced MT1-MMP expression in MDA-MB-231 human breast cancer cells
21. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism
22. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
23. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
24. Matrix metalloproteinase inhibition by green tea catechins
25. Brefeldin A revealing the fundamental principles governing membrane dynamics and protein transport
26. Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: Enhancement by paclitaxel and inhibition by nocodazole
27. Ras pathway is required for the activation of MMP-2 secretion and for the invasion of src-transformed 3Y1
28. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1
29. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
30. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
31. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
32. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain
33. Tumor gelatinases and invasion inhibited by the green tea flavonol epigallocatechin-3-gallate
34. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells
35. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols
36. Black tea, green tea, and tea polyphenols. Effects on trace element status in weanling rats
37. Angiogenesis inhibited by drinking tea
38. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells
39. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity
40. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols
41. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability
42. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium
43. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells
44. Expression of early growth response genes in human prostate cancer
45. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1
46. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2)
47. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1
48. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro
49. Antimutagenic and anticarcinogenic activity of tea polyphenols
50. The activation of proMMP-2 (gelatinase A) by HT-1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
51. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation
52. Calmodulin inhibitors trigger the proteolytic processing of membrane-type 1 matrix metalloproteinase but not its shedding in glioma cells